| Vol. 11.16 – 27 April, 2022 |
| |
|
|
| Scientists revealed a novel function of chaperone-mediated autophagy as an intrinsic regulator of glioma stem cell tumorigenic properties and highlighted its relevance in glioblastoma progression. [Autophagy] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| The authors examined the mechanism by which nicotine promoted lung cancer brain metastasis. They conducted a retrospective analysis of 810 lung cancer patients with a smoking history and assessed brain metastasis. [Oncogene] |
|
|
|
| Researchers uncovered penfluridol suppressed in vitro cell growth and in vivo tumorigenicity of various renal cell carcinoma (RCC) cell lines and enhanced the Sutent-triggered growth inhibition on clear cell RCC cell lines. [Cell Death & Disease] |
|
|
|
| Scientists compared the signature of CD34+ stem/progenitor cells collected from chronic myeloid leukemia individuals with that of healthy donors and observed significant changes in the abundance of enzymes associated with aerobic central carbonate metabolic pathways. [Cell Death & Disease] |
|
|
|
| SLFN11 expression was evaluated in tumor samples and characterized in circulating tumor cells (CTC) longitudinally to determine its potential role as a biomarker of response. [British Journal of Cancer] |
|
|
|
| The authors demonstrated that the molecular mechanisms of angiopoietin-like protein 1 (ANGPTL1) in colorectal CSC progression may have provided a novel therapeutic strategy for colorectal cancer. [Clinical Science] |
|
|
|
| Researchers reported that the voltage-gated calcium channel α2δ1 subunit-positive tumor-initiating cells of hepatocellular carcinoma specifically secreted LOX, forming a stiff extracellular matrix that was sufficient to drive the formation of tumor-initiating cells with a stiff mechanical trait. [Carcinogenesis] |
|
|
|
| Investigators explored the effect of colorectal cancer (CRC) stem cells-derived exosomes conveying miR-17-5p on CRC. [Cell Death Discovery] |
|
|
|
| The remarkable activity of complex 1 was observed not only in rhabdomyosarcoma cells cultured in 2D monolayers but, more importantly, also in 3D spheroids, which resembled in many aspects solid tumors and served as a promising model to mimic the in vivo situation. [Chemico-Biological interactions] |
|
|
|
| The viability, proliferation, stemness, and migration of CD133+/CD44+, CD133−/CD44−, and colorectal cancer cells after transfection or the co-culture with exosomes were detected by MTT, colony formation, spheroid, and wound healing assays, respectively. [Bioengineered] |
| |
|
|
|
| Scientists evaluate the mechanism of cancer stemness maintenance of liver cancer stem cells (LCSCs) and discuss promising treatments for eradicating LCSCs. [Cell Death & Disease] |
|
|
|
|
| Allogene Therapeutics, Inc. announced that the US FDA has granted orphan-drug designation to ALLO-605, the company’s next-generation allogenic CAR T product candidate targeting BCMA for the treatment of multiple myeloma. [Allogene Therapeutics, Inc.] |
|
|
|
|
| May 12 – May 14, 2022 Yokohama, Japan |
|
|
|
|
|
| Johns Hopkins University – Baltimore, Maryland, United States |
|
|
|
| McGill University – Montreal, Quebec, Canada |
|
|
|
| Cyprus Cancer Research Institute – Nicosia, Cyprus |
|
|
|
| The University of Hong Kong – Hong Kong, China |
|
|
|
| Luxembourg Institute of Health – Strassen, Luxembourg |
|
|
|
|